Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Viral vector bioprocessing & analytics: tools and innovations to meet future demand
Guest Editor:
Nolan Sutherland, Scientist, Molecular and Vector Biology at bluebird bio
Nolan Sutherland
Scientist, Molecular and Vector Biology at bluebird bio
April 2020
Sponsors
Co-sponsor
Download full spotlight
AAV downstream processing for industrial scale production – moving towards commercial manufacturing
Orjana Terova, Senior Product Manager, POROS Chromatography Product Line at Thermo Fisher Scientific
Mikhail Goldfarb, Principal Scientist, Downstream Process Development at Regenxbio, Inc
20 May 2020
Webinar
Watch now
Scaling AAV vector manufacture: overcoming roadblocks to the translation of gene therapies
N Faust
15 May 2020
Interview
Read more
What is ‘quality’ in viral vector manufacture? Strengths and limitations of current analytical tools
M Hörer
5 May 2020
Interview
Read more
Vector production in academia: obstacles and opportunities
D Bischof,
E Hopewell
5 May 2020
Interview
Read more
Drawing parallels and cross-pollinating ideas between viral vector and vaccine fields
A Kamen
5 May 2020
Interview
Read more
Lentiviral vector manufacturing process enhancement utilizing TFDF
™
technology
T Williams,
O Goodyear,
L Davies
et al.
5 May 2020
Expert Insight
Read more
Stable AAV producer cell lines: elevating vector manufacturing
Silke Wissing, Chief Scientific Officer
5 May 2020
Webinar
Watch now
Development and validation of quantitative real-time PCR for the detection of residual HEK-293 host cell DNA
K Norman
29 April 2020
Innovator Insight
Read more
Advances in gene therapy delivery: next-generation transfection reagent for large-scale AAV manufacturing
Mathieu Porte, BioProduction R&D Manager, Polyplus-transfection
Malik Hellal, Senior Scientist, Chemistry at Polyplus-transfection
29 April 2020
Webinar
Watch now
A reproducible, high-throughput platform to quantitatively study AAVs
J White,
N Rodionova
28 April 2020
Innovator Insight
Read more
How are fixed-bed bioreactors set to change viral vector processing?
P Velthof,
P Puri,
J Van Vliet
28 April 2020
Interview
Read more
Are suspension-based systems for cell and gene therapy key to commercial-scale manufacture?
P
27 April 2020
Interview
Read more
Scaling up viral vector manufacturing with adherent and suspension cell cultures
Clive Glover, Director, Strategy at Pall Biotech
Rachel Legmann, Senior Cell Culture Process Development Manager at Pall Biotech
Siddharth Gupta, Senior Bioprocess Specialist at Pall Biotech
21 April 2020
Webinar
Watch now
Lentiviral vector process to accelerate cell and gene therapy clinical development and commercialization
Kevin Beck, Senior Account Manager at Lentigen Technology Inc
16 April 2020
Webinar
Watch now
×
Please enter your email to register
Register